Close panel

Close panel

Close panel

Close panel

Innovation

Innovation

Gaucher's disease is a rare pathology affecting one out of every 50,000 live births in its least aggressive form, and one out of every 100,000 births in its more serious variant. Andrés Klein, a cell and molecular biologist and researcher at the Weizmann Institute (Israel), found it interesting that a single mutated gene could provoke several forms of the disease, some of which are fatal and others chronic. So he embarked on research to find a way of predicting how each patient would be affected, and thus achieve early diagnosis and more individualized treatment. This is one of the reasons he was selected as one of the MIT Technology Review Innovators under 35, in its Chilean edition in 2013.